Análise do pré-transplante renal no Brasil – modelagem da linha de cuidados e abordagem de custos top-down sob a perspectiva do Sistema Único de Saúde
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Introduction: Chronic Kidney Disease (CKD) is characterized by the progressive and
irreversible loss of renal function. Its definition was systematized in 2002 by the Kidney
Disease Outcomes Quality Initiative (KDOQI), which established diagnostic and
classification criteria. In 2012, these parameters were revised and expanded by Kidney
Disease Improving Global Outcomes (KDIGO), promoting international standardization
of management guidelines. The International Society of Nephrology reports that CKD
affects over 850 million people worldwide. By 2040, CKD is projected to become the
fifth leading cause of years of life lost globally. Although kidney transplantation is the
most effective treatment for CKD, it depends on a compatible donor and a
multidisciplinary evaluation encompassing clinical, bureaucratic, and economic
criteria. In Brazil, where the Unified Health System (Sistema Único de Saúde -SUS) is
the primary funder of transplant, a detailed understanding of pre-transplants costs is
essential for resource optimization. However, this topic remains underexplored and
lacks rigorous cost-analysis methodologies. Objective: This study aimed to conduct
an economic analysis of the pre-transpant costs for kidney recipients, living donors
(LD), and deceased donors (DD) across each stage of the care pathway, using a topdown micro-costing approach from the SUS perspective. Additionally, it sought to
model the care pathway for kidney transplantation with both LD and DD based on
production records from DATASUS. Method: A retrospective cohort study was
conducted over a ten-year period (2012–2022), including kidney donors
living/deceased and recipients. Data were sourced from the National Transplant
System (SNT) and DATASUS. AS the data are publicly accessible, ethics committee
approval was not required, in accordance with Brazilian Law 12,527 (November
18,2011). Methodological steps followed the Consolidated Health Economic
Evaluation Reporting Standards (CHEERS). The care pathway was modeled by
integrating procedures listed in SUS/SIGTAP Table group 05 – organ, tissue and cell
transplants – including all items related to the evaluation of kidney recipients and
donors. Costs were calculated in Brazilian reais (BRL). A statistical model was
developed to simulate pre-transplant demand, accounting for variability and
irregularities in SUS data. Results: The annual cost of evaluating LDs was BRL
7,656,267.77; for DDs< BRL 93,384,340.54; and for recipients, BRL 75,665,688.25.
DD evaluation represented the largest share of total costs. Among procedures,
immunological tests were the most intensive resource. Procedure 0501050019
(reactivity assessment of the recipient against panel in hypersensitized organ
recipients) was the costliest for recipients (BRL 47,684,772.90), while procedure
0501040064 (crossmatch testing for deceased donor recipients) incurred the highest
cost in DD evaluation. Conclusion: This study provides a novel and detailed mapping
of pre-transplant kidney costs within SUS, applying CHEERS criteria. DD evaluation
accounted for the largest portion of costs, with immunological testing representing the
most significant investment among procedures.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

